Cell growth and p53 expression in primary acquired melanosis and conjunctival melanoma

Journal of Clinical Pathology

Volumn 49, Issue 4, 1996, Pages 338-342

  Seregard, S ^a  

^a ST ERIK S EYE HOSPITAL   (Sweden)

Author keywords

Cell proliferation; Malignant transformation; p53 expression; Primary acquired melanosis; Recurrent conjunctival melanoma

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CELL GROWTH; CLINICAL ARTICLE; CONJUNCTIVA TUMOR; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MELANOSIS; PRIORITY JOURNAL; PROGNOSIS;

EID: 0029930477     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.49.4.338     Document Type: Article

References (37)

1. Seregard S, Kock E. Conjunctival malignant melanoma in Sweden 1969-91. Acta Ophthalmol (Copenh) 1992;70: 289-96.
2. DePotter P, Shields CL, Shields JA, Menduke H. Clinical predictive factors for development of recurrence and metastasis in conjunctival melanoma: a review of 68 cases. Br J Ophthalmol 1993;77:624-30.
3. Paridaens ADA, McCartney ACE, Minassian DC, Hungerford JL. Orbital exenteration in 95 cases of primary conjunctival malignant melanoma. Br J Ophthalmol 1994; 78:520-8.
4. Folberg R, McLean IW, Zimmerman LE. Primary acquired melanosis of the conjunctiva. Hum Pathol 1985;16:129-35.
5. Landberg G, Roos G. Antibodies to proliferating cell nuclear antigen as S-phase probes in flow cytometric analysis. Cancer Res 1991;51:4570-4.
6. Seregard S. Cell proliferation as a prognostic indicator in conjunctival malignant melanoma. Am J Ophthalmol 1993; 116:93-7.
7. Levine AJ, Momand J. Tumor suppressor genes: the p53 and retinoblastoma sensitivity genes and gene products. Biochim Biophys Acta 1990;1032:119-36.
8. Baker SJ, Fearon ER, Nigro JM, Hamilton S, Preisinger AC, Jessup JM, et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 1989; 244:217-21.
9. Nigro JM, Baker SJ, Preisinger AC. Mutations in the p53 gene occur in diverse human tumour types. Nature 1989; 342:705-8.
10. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 Mutations in human cancers. Science 1991;253:49-53.
11. Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature 1991;351:453-6.
12. Leong AS-Y, Milios J, Duncis CG. Antigen preservation in microwave irradiated tissues: a comparison with formaldehyde fixation. J Pathol 1988;156:275-82.
13. Shi S-R, Key ME, Kalra KL. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991; 39:741-8.
14. Taylor CR, Shi S-R, Chaiwun B, Young L, Imam SA, Cote RJ. Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections: androgen receptor, estrogen receptor, progesterone receptor, p53 protein, proliferating cell nuclear antigen and Ki67 antigen revealed by antigen retrieval techniques. Hum Pathol 1994;25:263-70.
15. Matias-Guiu X, Cuatrecasas M, Musulen E, Prat J. p53 expression in anaplastic carcinomas arising from thyroid papillary carcinomas. J Clin Pathol 1994;47:337-9.
16. Barbareschi M, Iuzzolini P, Pennella A, Allegraza A, Arrigoni G, Della Palma P, et al. p53 protein expression in central nervous system neoplasms. J Clin Pathol 1992;45:583-6.
17. Korkolopoulou P, Oates J, Crocker J, Edwards C. p53 expression in oat and non-oat small cell lung carcinomas: correlations with proliferating cell nuclear antigen. J Clin Pathol 1993;46:1093-6.
18. Poller DN, Roberts EC, Bell JA, Elston CW, Blamey RW, Ellis IO. p53 Protein expression in mammary ductal carcinoma in situ: Relationship to immunohistochemical expression of estrogen receptor and c-erbB-2 protein. Hum Pathol 1993;24:463-8.
19. Wee A, Teh M, Raju GC. Clinical importance of p53 protein in gall bladder carcinoma and its precursor lesions. J Clin Pathol 1994;47:453-6.
20. Folberg R, McLean IW, Zimmerman LE. Conjunctival melanoma and melanosis. Ophthalmology 1984;91:673-8.
21. Wolf H, Dittrich KL. Detection of proliferating cell nuclear antigen in diagnostic histopathology. J Histochem Cytochem 1942;40:1269-73.
22. Greenwell A, Foley JF, Maronpot RR. An enhancing method for immunohistochemical staining of proliferating cell nuclear antigen in archival rodent tissues. Cancer Lett 1991; 59:251-6.
23. Haerslev T, Jacobsen GK. Microwave processing for immunohistochemical demonstration of proliferating cell nuclear antigen (PCNA) in formalin-fixed and paraffin-embedded tissue. APMIS 1994;102:395-400.
24. Sasano H, Miyazaki S, Gooukon Y, Nishihira T, Sawai T, Nagura H. Expression of p53 in human esophageal carcinoma: An immunohistochemical study with correlation to proliferating cell nuclear antigen expression. Hum Pathol 1992;23:1238-43.
25. Stretch JR, Gatter KC, Raltkiaer E, Lane DP, Harris AL. Expression of mutant p53 in melanoma. Cancer Res 1991; 51:5976-9.
26. Akslen LA, Morkve O. Expression of p53 protein in cutaneous melanoma. Int J Cancer 1992;52:13-16.
27. McGregor JM, Yu CC-W, Dublin EA, Barnes DM, Levison DA, MacDonald DM. p53 immunoreactivity in human malignant melanoma and dysplastic naevi. Br J Dermatol 1993;128:606-11.
28. Weiss J, Schwechheimer K, Cavence WK, Herlyn M, Arden KC. Mutation and expression of the p53 gene in malignant melanoma cell lines. Int J Cancer 1993;54:693-4.
29. Lassam NJ, From L, Kahn HJ. Overexpression of p53 is a late event in the development of malignant melanoma. Cancer Res 1993;53:2235-8.
30. Platz A, Ringborg U, Grafström E, Höög A, Lagerlöf B. Immunohistochemical analysis of the N-ras p21 and the p53 proteins in naevi, primary tumours and metastases of human cutaneous malignant melanoma: increase immunopositivity in hereditary melanoma. Melanoma Res 1995;5:101-6.
31. Tobal K, Warren W, Cooper CS, McCartney A, Hungerford J, Lightman S. Increased expression and mutation of p53 in choroidal melanoma. Br J Cancer 1992;66:900-4.
32. Jay M, McCartney ACE: Familial malignant melanoma of the uvea and p53: A Victorian detective story. Surv Ophthalmol 1993;37:457-62.
33. Esrig D, Spruck CH III, Nichols PW, Chaiwun B, Steven K, Groshen S, et al. p53 Nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am J Pathol 1993;143:1389-97.
34. Cordon-Cardo C, Dalbagni G, Saez GT, Oliva MR, Zhang Z-F, Rosai J, et al. p53 Mutations in human bladder cancer: Genotypic versus phenotypic patterns. Int J Cancer 1994;56:347-53.
35. Scarpa A, Capelli P, Mukai K, Zamboni G, Oda T, Iacono C, et al. Pancreatic adenocarcinomas frequently show p53 gene mutations. Am J Pathol 1993;142:1534-43.
36. Kennedy SM, MacGeogh C, Jaffe R, Spurr NK. Overexpression of the oncoprotein p53 in primary hepatic tumors of childhood does not correlate with gene mutations. Hum Pathol 1994;25:438-42.
37. Vogelstein B. A deadly inheritance. Nature 1990;348:681-2.